Divon M Y, Girz B A, Lieblich R, Langer O
Department of Obstetrics and Gynecology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461.
Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1523-7. doi: 10.1016/0002-9378(89)90917-4.
This study was conducted to evaluate prospectively a management protocol for fetuses with a markedly abnormal umbilical artery velocity waveform. The study population consisted of fetuses whose systolic/diastolic ratio was greater than 2 SD above the mean for gestational age. The matched control population consisted of fetuses with similar gestational ages, indications for testing, and estimated fetal weights with normal systolic/diastolic ratios. Abnormal Doppler results were used only to determine the frequency of fetal testing. Biophysical profile testing was performed semiweekly on all patients. Patients with absent or reversed end-diastolic flow were admitted for daily testing. The following criteria were used as indications for delivery: (1) worsening maternal condition, (2) oligohydramnios, (3) intrauterine growth retardation with lung maturity, and (4) biophysical profile score less than or equal to 4. Fifty-one patients (7%) had abnormal Doppler blood flow velocity studies. When the study population was compared with the control population at the time of delivery, there were no differences in umbilical artery pH, Apgar score, or incidence of intrauterine growth retardation. However, study patients were delivered at a significantly lower gestational age and lower birth weight and experienced a higher likelihood of neonatal intensive care unit admission. When study patients with documented end-diastolic flow were compared with study patients with no end-diastolic flow, there were no differences in umbilical artery pH, Apgar score, or incidence of intrauterine growth retardation. However, fetuses with no end-diastolic flow had a significantly shorter test-to-delivery interval, lower gestational age, lower birth weight, and more neonatal intensive care unit admissions. There were no perinatal deaths among the study patients. The range of systolic/diastolic ratios for the five patients who failed to follow our protocol for intensive maternal-fetal surveillance was 4.3 to infinity; all experienced fetal death within 18 days. These results suggest that immediate delivery of the fetus with diminished end-diastolic flow may not be mandatory. The combined use of fetal biophysical testing and commonly used criteria for delivery results in acceptable fetal outcome and prolongation of gestational age.
本研究旨在前瞻性评估一种针对脐动脉速度波形明显异常胎儿的管理方案。研究人群包括收缩压/舒张压比值高于胎龄均值2个标准差以上的胎儿。匹配的对照人群由胎龄、检查指征和估计胎儿体重相似且收缩压/舒张压比值正常的胎儿组成。异常的多普勒结果仅用于确定胎儿检查的频率。所有患者均每两周进行一次生物物理评分检查。出现舒张末期血流消失或反向的患者需住院每日检查。以下标准用作分娩指征:(1)母亲病情恶化;(2)羊水过少;(3)伴有肺成熟的宫内生长受限;(4)生物物理评分小于或等于4分。51例患者(7%)的多普勒血流速度研究结果异常。在分娩时将研究人群与对照人群进行比较,脐动脉pH值、阿氏评分或宫内生长受限的发生率并无差异。然而,研究组患者的分娩孕周和出生体重显著较低,且入住新生儿重症监护病房的可能性更高。将有舒张末期血流记录的研究组患者与无舒张末期血流的研究组患者进行比较,脐动脉pH值、阿氏评分或宫内生长受限的发生率并无差异。然而,无舒张末期血流的胎儿检查至分娩间隔明显更短,孕周更低,出生体重更低,且入住新生儿重症监护病房的情况更多。研究组患者中无围产期死亡病例。未遵循我们的强化母胎监测方案的5例患者的收缩压/舒张压比值范围为4.3至无穷大;所有患者均在18天内发生胎儿死亡。这些结果表明,对于舒张末期血流减少的胎儿,立即分娩可能并非必要。胎儿生物物理检查与常用分娩标准联合使用可带来可接受的胎儿结局并延长孕周。